The delegation was received by Chairman of the Board Dr. Akram Jerab, CEO Dr. Khaled Harb, and several members of the executive management. During the visit, the company presented its latest developments, as well as the challenges and opportunities facing Jordanian companies and the pharmaceutical industry in general.
Dr. Al-Hasban emphasized the importance of continued coordination with relevant authorities to support the sustained growth and expansion of Jordanian companies. He also praised the company’s outstanding regional presence and the high competency of its Jordanian workforce.
Copyright © 2025 Dar Aldawa | All Rights served | Privacy Policy